Measurement of 3β-hydroxysteroid Δ7-reductase activity in cultured skin fibroblasts utilizing ergosterol as a substrate: A new method for the diagnosis of the Smith-Lemli-Opitz syndrome

Journal of Lipid Research

Volumn 37, Issue 11, 1996, Pages 2433-2438

  Honda, Megumi ^a   Tint, G S ^a   Honda, Akira ^a   Batta, Ashok K ^a   Chen, Thomas S ^a   Shefer, Sarah ^a   Salen, Gerald ^a  

^a NONE

Author keywords

7 dehydrocholesterol; Brassicasterol; Cholesterol; Gas chromatography mass spectrometry

Indexed keywords

3(OR 17)BETA HYDROXYSTEROID DEHYDROGENASE; 7 DEHYDROCHOLESTEROL; BRASSICASTEROL; CHOLESTEROL; ERGOSTEROL;

ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME SUBSTRATE; FIBROBLAST CULTURE; GAS CHROMATOGRAPHY; HUMAN; HUMAN CELL; MASS SPECTROMETRY; MEASUREMENT; PRIORITY JOURNAL; SKIN FIBROBLAST; SMITH LEMLI OPITZ SYNDROME;

CHOLESTADIENOLS; ERGOSTEROL; FIBROBLASTS; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; OXIDOREDUCTASES; OXIDOREDUCTASES ACTING ON CH-CH GROUP DONORS; PHYTOSTEROLS; SKIN; SMITH-LEMLI-OPITZ SYNDROME; STIGMASTEROL;

EID: 0030454107     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Smith, D. W., L. Lemli, and J. M. Opitz. 1964. A newly recognized syndrome of multiple congenital anomalies. J. Pediatr. 64: 210-217.
2. Honda, A., G. S. Tint, G. Salen, A. K. Batta, T. S. Chen, and S. Shefer. 1995. Defective conversion of 7-dehydrocholesterol to cholesterol in cultured skin fibroblasts from Smith-Lemli-Opitz syndrome homozygotes. J. Lipid Res. 36: 1595-1601.
3. 7-reductase activity in liver microsomes from Smith-Lemli-Opitz homozygotes. J. Clin. Invest. 96: 1779-1785.
4. Chasalow, F. I., S. L. Blethen, and K. Taysi. 1985. Possible abnormalities of steroid secretion in children with Smith-Lemli-Opitz syndrome and their parents. Steroids. 46: 827-843.
5. Curry, C. J. R., J. C. Carey, J. S. Holland, D. Chopra, R. Fineman, M. Golabi, S. Sherman, R. A. Pagon, J. Allanson, S. Shulman, M. Barr, V. McGravey, C. Dabiri, N. Schimke, E. Ives, and B. D. Hall. 1987. Smith-Lemli-Opitz syndrome-type II: multiple congenital anomalies with male pseudohermaphroditism and frequent early lethality. Am. J. Med. Genet. 26: 45-57.
6. Gorlin, R. J., M. M. Cohen, Jr., and L. S. Levin. 1990. Syndromes of the Head and Neck. 3rd ed. Oxford University Press, New York, NY. 890-895.
7. Pober, B., C. J. R. Curry, and J. C. Rutledge. 1990. Smith-Lemli-Opitz syndrome. In Birth Defects Encyclopedia. M. L. Buyse, editor. Center for Birth Defects Information Services, in association with Blackwell Scientific, Dover, MA. 1570-1572.
8. Irons, M., E. R. Elias, G. Salen, G. S. Tint, and A. K. Batta. 1993. Defective cholesterol biosynthesis in Smith-Lemli-Opitz syndrome. Lancet. 341: 1414.
9. Tint, G. S., M. Irons, E. R. Elias, A. K. Batta, R. Frieden, T. S. Chen, and G. Salen. 1994. Defective cholesterol biosynthesis associated with the Smith-Lemli-Opitz syndrome. N. Engl. J. Med. 330: 107-113.
10. Tint, G. S., G. Salen, A. K. Batta, S. Shefer, M. Irons, E. R. Elias, D. N. Abuelo, V. P. Johnson, M. Lambert, R. Lutz, C. Schanen, C. A. Morris, G. Hoganson, and R. Hughes-Benzie. 1995. Correlation of severity and outcome with plasma sterol levels in variants of the Smith-Lemli-Opitz syndrome. J. Pediatr. 127: 82-87.
11. Kelley, R. I. 1995. Diagnosis of Smith-Lemli-Opitz syndrome by gas chromatography/mass spectrometry of 7-dehydrocholesterol in plasma, amniotic fluid and cultured skin fibroblasts. Clin. Chim. Acta. 236: 45-58.
12. 7-reductase activity in cultured human fibroblasts: a method for the diagnosis of Smith-Lemli-Opitz syndrome. J. Inher. Metab. Dis. 19: 59-64.
13. 3 in human skin and the physiologic consequences. Science. 210: 203-205.
14. 3 photosynthesis in man: skin pigment is not an essential regulator. Science. 211: 590-593.
15. 7-cholestenol, but not cholestanol, in cultured fibroblasts from normal individuals and patients with cerebrotendinous xanthomatosis. J. Lipid Res. 23: 597-603.
16. Folch, J., M. Lees, and G. H. Sloane Stanley. 1957. A simple method for the isolation and purification of total lipides from animal tissues. J. Biol. Chem. 226: 497-509.
17. 7-cholestenol, by thin-layer chromatography. J. Lipid Res. 6: 438-441.
18. Tint, G. S., and G. Salen. 1974. Transformation of 5α-cholest-7-en-3β-ol to cholesterol and cholestanol in cerebrotendinous xanthomatosis. J. Lipid Res. 15: 256-262.
19. 7-reductase. J. Biol. Chem. 271: 10866-10873.
20. Alley, T. L., B. A. Gray, S-H. Lee, S. W. Scherer, L-C. Tsui, G. S. Tint, C. A. Williams, R. Zori, and M. R. Wallace. 1995. Identification of a yeast artificial chromosome clone spanning a translocation breakpoint at 7q32.1 in a Smith-Lemli-Opitz syndrome patient. Am. J. Hum. Genet. 56: 1411-1416.
21. 5,7,22-cholestatrien-3β-ol by a liver enzyme. Lipids. 16: 755-758.
22. Clejan, S., and R. Bittman. 1984. Distribution and movement of sterols with different side chain structures between the two leaflets of the membrane bilayer of mycoplasma cells. J. Biol. Chem. 259: 449-455.
23. Honda, A., S. Shefer, G. Salen, G. Xu, A. K. Batta, G. S. Tint, M. Honda, T. C. Chen, and M. F. Holick. 1996. Regulation of the last 2 enzymatic reactions in cholesterol biosynthesis in rats: effects of BM 15.766, cholesterol, cholic acid, lovastatin, and their combinations. Hepatology. 24: 435-439.
24. Xu, G., G. Salen, S. Shefer, G. C. Ness, T. S. Chen, Z. Zhao, and G. S. Tint. 1995. Reproducing abnormal cholesterol biosynthesis as seen in the Smith-Lemli-Opitz syndrome by inhibiting the conversion of 7-dehydrocholesterol to cholesterol in rats. J. Clin. Invest. 96: 76-81.
25. Xu, G., G. Salen, S. Shefer, G. C. Ness, T. S. Chen, Z. Zhao, L. Salen, and G. S. Tint. 1995. Treatment of the cholesterol biosynthetic defect in Smith-Lemli-Opitz syndrome reproduced in rats by BM 15.766. Gastroenterology. 109: 1301-1307.
26. Axelson, M. 1991. Occurrence of isomeric dehydrocholesterols in human plasma. J. Lipid Res. 32: 1441-1448.
27. Irons, M., E. R. Elias, G. S. Tint, G. Salen, R. Frieden, T. M. Buie, and M. Ampola. 1994. Abnormal cholesterol metabolism in the Smith-Lemli-Opitz syndrome: report of clinical and biochemical findings in four patients and treatment in one patient. Am. J. Med. Genet. 50: 347-352.